Site Search
Trauma-List Subscription


Would you like to receive list emails batched into one daily digest?
No Yes
Modify Your Subscription


Home > List Archives

Colon Cancer post GSW

Charles Brault c_brault at yahoo.com
Wed May 18 07:10:13 BST 2011


From: Miki <muggia at bezeqint.net>
To: trauma-list at trauma.org
Sent: Tue, May 17, 2011 7:53:59 PM
Subject: Colon Cancer post GSW

Staying on this topic :

Detecting colorectal cancer in its early, curable, stages is the goal behind 
Phenomenome Discoveries Inc.'s licensing of a diagnostic blood test in 

Colorectal cancer is the second most commonly diagnosed cancer and the second 
leading cause of cancer death in both men and women. Every year approximately 
650 people are diagnosed with colorectal cancer in this province and 250 people 
die from the disease. 

Phenomenome Discoveries Inc.'s test measures blood levels of a novel metabolite 
that is low in people with colorectal cancer. 

"This is an encouraging development right here in Saskatchewan that will help 
with the early detection of cancer," Premier Brad Wall said. "This has the 
potential to make a big difference to Saskatchewan people dealing with cancer." 

"Determining cancer risk through a blood test has the potential to strengthen 
cancer care for Saskatchewan people, something that is a high priority for our 
government," Health Minister Don McMorris said. 

The trial for the blood test took place over two years and involved more than 
5,000 patients in the Regina Qu'Appelle Health Region. The results of this 
clinical trial indicate that the test led to the diagnosis of 87 per cent of 
early stage cancers, making it the most sensitive blood test available for 
colorectal cancer.

"Colorectal cancer is more than 90 per cent preventable and easily treated when 
found in the early stages," Saskatchewan Cancer Agency Chief Executive Officer 
Scott Livingstone said. "Finding ways to detect and prevent the disease is an 
important aspect of our work in the fight against cancer." 

"We are pleased to be able to detect such high rates of early stage colorectal 
cancer using a non-invasive blood test, and that Saskatchewan will be the first 
province to license the right to use it," Phenomenome Discoveries Inc. Chief 
Executive Officer Dr. Dayan Goodenowe said. 

Saskatchewan has made reducing colorectal cancer mortality a priority. 
Continuing to expand screening programs that detect early stage cancer is the 
best way to achieve this goal, allowing Saskatchewan to maintain a leadership 
role in cancer screening. 

For more information, contact: 
Tyler McMurchy
Phone: 306-787-4083
Email: tyler.mcmurchy at gov.sk.ca
Cell: 306-537-3594 
Gladys Wasylenchuk
Saskatchewan Cancer Agency
Phone: 306-791-2144
Email: gladys.wasylenchuk at saskcancer.ca
Cell: 306-501-7366 
Alix Hayden
Phenomenome Discoveries Inc.
Phone: 306-244-8233 ex 210
Cell: 306-229-4029 

1.      Could there be any connection between the severe injury and the
sigmoid cancer?

Do not most cancer have as it's (co)trigger an injury (Viral, bacterial, 
chemical, traumatic )?

More information about the trauma-list mailing list